Ascentage Pharma Group International
Price & Volume
Stats
See more52W Range | $16.50-$48.45 |
Market Cap | $3B |
Shares Short | 2,864 |
Financials
See moreRevenue (12 Mos) | $390.6M |
Revenue Growth (YoY) | -71.6% |
Gross Profit (12 Mos) | $354.9M |
Diluted EPS | -$2.05 |
News
See moreYahoo Finance • 3 days ago
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy
Yahoo Finance • 9 days ago
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
Yahoo Finance • 19 days ago
Asian Growth Stocks With High Insider Ownership In November 2025
Yahoo Finance • 23 days ago
Pinterest downgraded, Tractor Supply upgraded: Wall Street's top analyst calls
About
CEO | Dr. Dajun Yang M.D., Ph.D. |
Address | Suzhou Industrial Park, Suzhou, China, 215000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 605 |
